FR3092994B1 - Utilisation de peptides cycliques fongiques de type destruxine comme agents antibactériens actifs contre Clostridium perfringens - Google Patents

Utilisation de peptides cycliques fongiques de type destruxine comme agents antibactériens actifs contre Clostridium perfringens Download PDF

Info

Publication number
FR3092994B1
FR3092994B1 FR1901896A FR1901896A FR3092994B1 FR 3092994 B1 FR3092994 B1 FR 3092994B1 FR 1901896 A FR1901896 A FR 1901896A FR 1901896 A FR1901896 A FR 1901896A FR 3092994 B1 FR3092994 B1 FR 3092994B1
Authority
FR
France
Prior art keywords
clostridium perfringens
destruxin
antibacterial agents
active against
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1901896A
Other languages
English (en)
Other versions
FR3092994A1 (fr
Inventor
Marc Maresca
Josette Perrier
Cendrine Nicoletti
Sybille Tachon
Clarisse Roblin
Michael Lafond
Hamza Olleik
Michel Fons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aix Marseille Universite
Centre National de la Recherche Scientifique CNRS
Original Assignee
Aix Marseille Universite
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aix Marseille Universite, Centre National de la Recherche Scientifique CNRS filed Critical Aix Marseille Universite
Priority to FR1901896A priority Critical patent/FR3092994B1/fr
Priority to US17/433,765 priority patent/US20220133842A1/en
Priority to PCT/EP2020/054877 priority patent/WO2020173926A1/fr
Priority to EP20708055.7A priority patent/EP3930741A1/fr
Publication of FR3092994A1 publication Critical patent/FR3092994A1/fr
Application granted granted Critical
Publication of FR3092994B1 publication Critical patent/FR3092994B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Utilisation de peptides cycliques fongiques de type d estruxine comme agents antibactériens actifs contre Clostridium perfringens La présente invention concerne l’utilisation d’une destruxine ou leurs dérivés pour prévenir ou lutter contre Clostridium perfringens, en thérapie humaine ou vétérinaire, ou en nutrition animale. Figure pour l'abrégé : aucune
FR1901896A 2019-02-25 2019-02-25 Utilisation de peptides cycliques fongiques de type destruxine comme agents antibactériens actifs contre Clostridium perfringens Active FR3092994B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1901896A FR3092994B1 (fr) 2019-02-25 2019-02-25 Utilisation de peptides cycliques fongiques de type destruxine comme agents antibactériens actifs contre Clostridium perfringens
US17/433,765 US20220133842A1 (en) 2019-02-25 2020-02-25 Use of fungal cyclic peptides of the destruxin type as antibacterial agents active against Clostridium perfringens
PCT/EP2020/054877 WO2020173926A1 (fr) 2019-02-25 2020-02-25 Utilisation de peptides cycliques fongiques de type destruxine comme agents antibactériens actifs contre clostridium perfringens
EP20708055.7A EP3930741A1 (fr) 2019-02-25 2020-02-25 Utilisation de peptides cycliques fongiques de type destruxine comme agents antibactériens actifs contre clostridium perfringens

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1901896A FR3092994B1 (fr) 2019-02-25 2019-02-25 Utilisation de peptides cycliques fongiques de type destruxine comme agents antibactériens actifs contre Clostridium perfringens
FR1901896 2019-02-25

Publications (2)

Publication Number Publication Date
FR3092994A1 FR3092994A1 (fr) 2020-08-28
FR3092994B1 true FR3092994B1 (fr) 2021-03-12

Family

ID=69104465

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1901896A Active FR3092994B1 (fr) 2019-02-25 2019-02-25 Utilisation de peptides cycliques fongiques de type destruxine comme agents antibactériens actifs contre Clostridium perfringens

Country Status (4)

Country Link
US (1) US20220133842A1 (fr)
EP (1) EP3930741A1 (fr)
FR (1) FR3092994B1 (fr)
WO (1) WO2020173926A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112480135B (zh) * 2020-11-26 2022-03-08 中山大学 一种含吡啶的杂萜类化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004518716A (ja) 2001-02-14 2004-06-24 ドン ワ ファーマシューティカル インダストリアル カンパニー リミテッド 骨多孔症予防および治療用医薬組成物
CN101433214B (zh) 2008-12-15 2011-04-27 华南农业大学 一种绿僵菌素与溴氰菊酯复配的杀虫主剂
CN106810601B (zh) 2017-01-13 2020-06-16 中国科学院海洋研究所 一种Destruxin类缩酚酸肽衍生物及其制备方法和应用

Also Published As

Publication number Publication date
WO2020173926A1 (fr) 2020-09-03
FR3092994A1 (fr) 2020-08-28
US20220133842A1 (en) 2022-05-05
EP3930741A1 (fr) 2022-01-05

Similar Documents

Publication Publication Date Title
MD3774791T2 (ro) Compuși heterociclici ca imunomodulatori
MX2020007944A (es) Nanocomplejos similares a los lípidos y sus usos.
MX2022015272A (es) Inhibidores de la proteina kras g12c y usos de estos.
MA53399B1 (fr) Pyrazoles substitués en tant qu`inhibiteurs de la kallicréine plasmatique humaine
MA38289A1 (fr) Composition pharmaceutique à biodisponibilité ameliorée
MA43763A (fr) Protéine f de pré-fusion du vrs soluble et stabilisée pour son utilisation dans la prophylaxie d'une infection vrs
BR112013010310A2 (pt) inibidores de acetil-coa carboxilase de lactama n1/n2
WO2020132661A3 (fr) Inhibiteurs de protéine d'activation des fibroblastes
WO2019133770A3 (fr) Inhibiteurs de glycolate oxydase pour le traitement de maladies
EA201101451A1 (ru) Гидрокситиенохинолоны и родственные соединения как противоинфекционные средства
UA83314C2 (ru) 2-(пиридин-2-ил)пиримидиновые соединения и их применение для борьбы с вредными грибами
WO2020126968A3 (fr) Dérivés d'urée
FR3065371B1 (fr) Composition pharmaceutique topique comprenant au moins de l'amitriptyline pour le traitement de douleurs neuropathiques peripheriques
MA43052B1 (fr) Inhibiteurs de la kallicréine plasmatique humaine
NZ788133A (en) Cd73 inhibitors
BR112021024271A2 (pt) Composições para tratamento bucal sem enxágue
MX2021007948A (es) Inhibidores de proteina de activacion de fibroblastos.
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
AU2019322713A8 (en) Novel medicament for treating inflammatory bowel disease
CO2020006789A2 (es) Procedimiento para la preparación de (3s)-3-(4-cloro-3-{[(2s,3r)-2-(4-clorofenil)-4,4,4-trifluor-3-metilbutanoil]amino}fenil)-3-ácido ciclopropilpropanoico y su forma cristalina para uso como principio activo farmacéutico
FR3092994B1 (fr) Utilisation de peptides cycliques fongiques de type destruxine comme agents antibactériens actifs contre Clostridium perfringens
MA41174B1 (fr) Dérivés d'imidazopyridazine utilisés en tant qu'inhibiteurs de pi3kbeta
MX2020008929A (es) Compuestos de dihidropirimidinona o dihidrotriazinona fusionados con anillos saturados y su uso farmaceutico.
FR2967062B1 (fr) Utilisation d'extrait de grenade pour prevenir et/ou traiter les poches perioculaires
AU2018329158A8 (en) Topically administrable formulation for the control and prevention of animal parasites

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20200828

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6